N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders
- PMID: 29651972
- PMCID: PMC6563911
- DOI: 10.2174/1871527317666180412153612
N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders
Abstract
Background & objective: A number of neuropsychiatric disorders, including Parkinson's disease, schizophrenia, attention deficit hyperactivity disorder, and, to some extent, depression, involve dysregulation of the brain dopamine systems. The etiology of these diseases is multifactorial, involving genetic and environmental factors. Evidence suggests that inadequate levels of n-3 (omega- 3) polyunsaturated fatty acids (PUFA) in the brain may represent a risk factor for these disorders. These fatty acids, which are derived from the diet, are a major component of neuronal membranes and are of particular importance in brain development and function. Low levels of n-3 PUFAs in the brain affect the brain dopamine systems and, when combined with appropriate genetic and other factors, increase the risk of developing these disorders and/or the severity of the disease. This article reviews the neurobiology of n-3 PUFAs and their effects on dopaminergic function.
Conclusion: Clinical studies supporting their role in the etiologies of diseases involving the brain dopamine systems and the potential of n-3 PUFAs in the treatment of these disorders are discussed.
Keywords: Dopamine; Parkinson's disease; attention deficit hyperactivity disorder; depression; omega-3; docosahexaenoic acid; schizophrenia..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Conflict of interest statement
Conflict of Interest
The authors have no conflicts of interest with respect to this work.
Similar articles
-
[The treatment of Attention-Deficit/Hyperactivity Disorders with polyunsaturated fatty acids - an effective treatment alternative?].Z Kinder Jugendpsychiatr Psychother. 2008 Mar;36(2):109-16. doi: 10.1024/1422-4917.36.2.109. Z Kinder Jugendpsychiatr Psychother. 2008. PMID: 18622940 Review. German.
-
Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease.Neurosci Res. 2010 Mar;66(3):256-64. doi: 10.1016/j.neures.2009.11.006. Epub 2009 Nov 24. Neurosci Res. 2010. PMID: 19941911
-
N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology.Int J Neuropsychopharmacol. 2016 Dec 30;19(12):pyw078. doi: 10.1093/ijnp/pyw078. Print 2016 Dec. Int J Neuropsychopharmacol. 2016. PMID: 27608809 Free PMC article. Review.
-
Omega-3 fatty acids and neuropsychiatric disorders.Reprod Nutr Dev. 2005 Jan-Feb;45(1):1-28. doi: 10.1051/rnd:2005001. Reprod Nutr Dev. 2005. PMID: 15865053 Review.
-
Randomized placebo-controlled trials of omega-3 polyunsaturated fatty acids in psychiatric disorders: a review of the current literature.Curr Drug Discov Technol. 2013 Sep;10(3):245-53. doi: 10.2174/1570163811310030007. Curr Drug Discov Technol. 2013. PMID: 21838664 Review.
Cited by
-
Impact of Flaxseed Oil Supplementation on Tobacco Dependence, Craving, and Haematological Parameters in Tobacco-Dependent Subjects.Cureus. 2024 Mar 28;16(3):e57101. doi: 10.7759/cureus.57101. eCollection 2024 Mar. Cureus. 2024. PMID: 38681370 Free PMC article.
-
Dietary Intakes of Long-Chain Polyunsaturated Fatty Acids and Impulsivity: Comparing Non-Restricted, Vegetarian, and Vegan Diets.Nutrients. 2024 Mar 18;16(6):875. doi: 10.3390/nu16060875. Nutrients. 2024. PMID: 38542786 Free PMC article.
-
Impacts of Omega-3 Fatty Acids, Natural Elixirs for Neuronal Health, on Brain Development and Functions.Methods Mol Biol. 2024;2761:209-229. doi: 10.1007/978-1-0716-3662-6_15. Methods Mol Biol. 2024. PMID: 38427239
-
Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers.Metabolites. 2024 Jan 23;14(2):80. doi: 10.3390/metabo14020080. Metabolites. 2024. PMID: 38392971 Free PMC article. Review.
-
Evidence or no evidence for essential fatty acids in the treatment of autism spectrum disorders?Front Nutr. 2023 Aug 31;10:1251083. doi: 10.3389/fnut.2023.1251083. eCollection 2023. Front Nutr. 2023. PMID: 37727635 Free PMC article. Review.
References
-
- Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 1998; 352: 688–91. - PubMed
-
- Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000; 42: 174–81. - PubMed
-
- Whelan J. (n-6) and (n-3) Polyunsaturated fatty acids and the aging brain: food for thought. J Nutr 2008; 138: 2521–2. - PubMed
-
- Dyall S, Michael-Titus A. Neurological benefits of omega-3 fatty acids. Neuromolecular Med 2008; 10: 219–35. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical